Article: How Polyphenols Support Blood Sugar Balance in Pre-Diabetes & Type 2 Diabetes
How Polyphenols Support Blood Sugar Balance in Pre-Diabetes & Type 2 Diabetes
by Dr. Steve Collins, 10 Feb. 2026
Maintaining tight control of blood glucose is one of the most important determinants of long-term metabolic health. In Pre-Diabetes and Type 2 Diabetes, the core problem is not simply elevated fasting glucose, but repeated postprandial glucose spikes accompanied by excessive insulin secretion. Over time, this pattern drives insulin resistance, β-cell dysfunction and damage, oxidative stress and glycation-related tissue damage (1,2).
Dietary polyphenols are increasingly recognised as important modulators of glucose metabolism, acting through mechanisms that are distinct from, and complementary to, fibre, protein and energy control. Critically, many of these effects occur within the gastrointestinal tract and do not require significant systemic absorption (1,3).
Polyphenols Act Where Glucose First Enters the Body
Polyphenols do not need to be absorbed into the circulation to exert clinically meaningful anti-glycaemic effects. Following ingestion, concentrations within the intestinal lumen are substantially higher than those detected in plasma and are sufficient to influence digestive enzymes, glucose transporters and probably most critical of all, enteroendocrine (incretin) signalling (1,3). The ability to act powerfully in the absence of high levels of classical ‘bioavailability’ is makes them particularly relevant for attenuating postprandial glycaemic peaks.
GLP-1 Modulation: a Central Mechanism
One of the most clinically important mechanisms by which polyphenols support glucose control is through modulation of glucagon-like peptide-1 (GLP-1). GLP-1 enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying and reduces appetite (4) and has recently assumed a much higher profile in the public consciousness due to the clinical success of pharmaceutical GLP-1 agonists such as Ozempic and Monjaro.
In contrast to artificial pharmaceutical GLP-1 agonists, polyphenols exert their action by increasing levels of endogenous GLP-1, both through stimulating its release and also through inhibiting its breaking down, thereby increasing its half life. Certain anthocyanins, including cyanidin-3-O-glucoside an anthocyanin found in aronia berries, have been shown to stimulate GLP-1 synthesis and secretion from intestinal L-cells via activation of the PPARβ/δ–β-catenin–TCF-4 signalling pathway (5). The PPARβ/δ–β-catenin–TCF-4 signalling pathway is increasingly recognised as an important regulatory pathway linking nutrient sensing in the gut to incretin secretion and glucose homeostasis, with emerging relevance to the pathophysiology of type 2 diabetes.
In parallel, chlorogenic acids such as caffeoylquinic acids found in unusually high concentrations in aronia juice, have been shown in diabetic rodent models to inhibit intestinal dipeptidyl peptidase-4 (DPP-4), the enzyme responsible for rapid GLP-1 degradation, thereby prolonging its biological activity and improving blood glucose control [6]. Similar improvements in blood glucose associated with aronia juice have been demonstrated in human randomised cross over trials (7). This dual action in increasing active GLP-1 overlaps with the physiological effects of modern GLP-1 agonists, but achieved with the body’s own GLP-1 rather than synthetic alternatives.
Protection and Support of Pancreatic β-cells
Chronic hyperglycaemia increases reactive oxygen species generation (free radicals) across the body but particularly within pancreatic β-cells, contributing to their progressive dysfunction. Polyphenols help mitigate this process both indirectly, by reducing postprandial glucose exposure, and directly, by enhancing cellular antioxidant defences and protecting β-cells from oxidative damage (2,3).
Anthocyanins and phenolic acids, which are abundant in berry fruits such as aronia, are particularly well characterised in this context and have been associated with improvements in insulin sensitivity and fasting and postprandial glucose control in human intervention studies (8,9).
Slowing Carbohydrate Digestion and Absorption
Polyphenols also reduce the rate at which glucose appears in the circulation after a meal by partially inhibiting the activity of α-amylase and α-glucosidase the intestinal enzymes that hydrolyse carbohydrates into simple sugars [7]. They also lower glucose flux through intestinal glucose transporters such as SGLT-1 and GLUT-2 (1,6). The practical consequence is slower glucose absorption into the portal circulation, resulting in a lower and broader postprandial glucose curve, reducing insulin demand and downstream metabolic stress.
Implications for Nutrition Practice
Although often touted for their pronounced antioxidant activity, for nutrition professionals working with Pre-Diabetes and Type 2 Diabetes, polyphenols should be viewed as dietary modulators of glucose handling rather than just generic antioxidants. Their benefits are greatest when consumed shortly before or alongside carbohydrate-containing meals and their effects are additive to established dietary strategies, such as lowering glycaemic levels of meals, increasing protein intake before carbohydrates and particularly increasing fibre intake. It is worth noting that there is great inter-individual variability in the clinical efficacy of polyphenols, probably largely due to interactions with the host microbiome. This makes supplementary short-term continuous glucose monitoring a useful tool for identifying the level of response both at the outset of interventions but also after a few months to chart changes in efficacy that can result from polyphenols and fibre enhancing the microbiome composition.
If you would like to know more or to see the full pdf versions of all references, we have these available so please do get in contact.
Dr. Steve Collins, Feb. 2026
References
1. Williamson G. Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res. 2013;57(1):48–57. https://doi.org/10.1002/mnfr.201200511
2. Kim YA, Keogh JB, Clifton PM. Polyphenols and glycaemic control. Nutrients. 2016;8(1):17. https://doi.org/10.3390/nu8010017
3. Fraga CG, Croft KD, Kennedy DO, Tomas-Barberan FA. The effects of polyphenols and other bioactives on human health. Food Funct. 2019;10(2):514–528. https://doi.org/10.1039/C8FO01997E
4. Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153–165. https://doi.org/10.1016/j.cmet.2006.01.004
5. Ye X, Chen W, Yan F, et al. Cyanidin-3-O-glucoside enhances GLP-1 secretion via the PPARbeta/delta–beta-catenin–TCF-4 pathway in type 2 diabetes mellitus. npj Sci Food. 2025. https://doi.org/10.1038/s41538-025-00445-4
6. Yamane T, Kozuka M, Konda D, et al. Improvement of blood glucose levels and obesity in mice given aronia juice by inhibition of dipeptidyl peptidase-4 and alpha-glucosidase. J Nutr Biochem. 2016;31:106–112. https://doi.org/10.1016/j.jnutbio.2016.02.004
7. Yamane T, Kozuka M, Wada-Yoneta M, et al. Aronia juice suppresses the elevation of postprandial blood glucose levels in adult healthy Japanese. Clin Nutr Exp. 2017;12:20–26. https://doi.org/10.1016/j.yclnex.2017.01.002
8. Milutinovic M, Radovanovic RV, Savikin K, et al. Chokeberry juice supplementation in type 2 diabetic patients. J Appl Biomed. 2019;17(2):64–71. https://doi.org/10.32725/jab.2019.020
9. Tasic N, Jakovljevic VLJ, Mitrovic M, et al. Black chokeberry extract improves glycaemic control in metabolic syndrome. Mol Cell Biochem. 2021;476(7):2663–2673. https://doi.org/10.1007/s11010-021-04106-4